Zuckerman, Jonathan E <br/><br/>
siRNA knockdown of ribonucleotide reductase inhibits melanoma cell line proliferation alone or synergistically with temozolomide.  [electronic resource] 

 -  The Journal of investigative dermatology  Feb 2011 
 - 453-60 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1523-1747 
<br/><br/><label>Standard No.: </label>10.1038/jid.2010.310  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents, Alkylating--pharmacology<br/>Cell Cycle--drug effects<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Dacarbazine--analogs & derivatives<br/>G1 Phase--drug effects<br/>Gene Silencing--drug effects<br/>Humans<br/>Melanoma--metabolism<br/>RNA, Small Interfering--pharmacology<br/>Ribonucleoside Diphosphate Reductase--genetics<br/>S Phase--drug effects<br/>Skin Neoplasms--metabolism<br/>Temozolomide